Conquering Diseases

A Study Of An Investigational Drug, In Combination With Other Drugs, For Certain Types Of Prostate Cancer

Description

Seeking men 18 years of age or older, for participation in a study of an investigational drug called Relugolix in combination with other drugs, for certain types of prostate cancer.

Overview

We are studying the effects of Relugolix in combination with other drugs, to determine how safe and how well these work in participants with certain types of prostate cancer.

What we're hoping for

To determine whether relugolix, in combination with other approved drugs is safe and well tolerated for the treatment of patients with certain types of prostate cancer.

Additional Information

ClinicalTrials.gov Identifier: NCT04666129

 Principal Investigator

Kriti  Mittal, MD, MS

UMass Memorial Health Care

 Study Contact

Declan  Lyons

declan.lyons1@umassmed.edu

 Location

UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989